ReviewTargeted oncology2021

Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective.

Xinrui Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.